These findings may be due to the direct effect of interactions between CD162 and E-selectin, as in our in vitro model we found that E-selectin-mediated chemo-resistance was abrogated when CD162 receptor was absent from the human CD34+ AML cell line KG1a. The gene discussed is SELPLG; the disease is acute myeloid leukemia.